KM Pharmaceutical Expands Exports in Asian Market with "Pororo Toothpaste" View original image

KM Pharmaceutical is accelerating its entry into the global market by expanding its business from China to other major Asian countries, including Vietnam, Malaysia, and Kuwait.


The company announced on July 2 that it is strengthening its global business competitiveness by expanding overseas exports centered on its flagship brand, "Pororo Toothpaste," while also diversifying its export portfolio to include functional cosmetics and life care products.


KM Pharmaceutical has been expanding its supply of oral care products in the Chinese and Vietnamese markets and has steadily established a foundation for overseas expansion, such as obtaining hygiene approval for children's oral care products in China. Recently, the company has been expanding its presence in the Asian market by moving beyond toothpaste and oral care products to focus on functional cosmetics and its own life care brands.


In the Chinese market, the company plans to continue increasing exports of Pororo Toothpaste and cosmetics products in the second half of the year, following the first half. At the same time, it is working to supply mouthwash products to the Kuwaiti market through an ODM model and is in discussions with local partners in Malaysia to export toothpaste and OEM mouthwash products within this year.


The overseas expansion of its life care brands is also gaining momentum. Since May, KM Pharmaceutical has begun exporting cosmetic products, including the "Zerocipe" scalp care brand's phytobiome sunscreen, to the Vietnamese market.


Zerocipe is strengthening its product development and brand competitiveness based on an exclusive license agreement for patented nanographene ingredient technology. The company aims to raise brand awareness among overseas consumers and secure a foundation for growth in the global market by leveraging this technological capability.


KM Pharmaceutical is transforming its business structure into a comprehensive life care company that covers both oral care and functional cosmetics, through a customized product supply strategy tailored to the consumption patterns and distribution environments of each country.


Based on the manufacturing competitiveness accumulated from its existing OEM and ODM business, the company is simultaneously nurturing its own brands and expanding into overseas markets to secure mid- to long-term growth drivers.


A KM Pharmaceutical representative stated, "The Asian market, including China, is a key region where demand for not only oral care but also functional cosmetics continues to grow. We will evolve into a global life care company by strengthening product competitiveness that reflects local consumer needs and expanding our brand portfolio."


Meanwhile, KM Pharmaceutical is moving away from its previous OEM and ODM-focused business structure for quasi-drugs, enhancing product competitiveness centered on functionality and ingredients, and driving change towards becoming a life care brand company. The company plans to seize new growth opportunities in domestic and international markets by expanding its oral care, functional cosmetics, and life care product lines.



KM Pharmaceutical is expected to accelerate its transformation into a global life care company by expanding exports focused on the Asian market and strengthening brand competitiveness.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing